Just noticed there's a class action lawsuit claiming that the sale wasn't fair to OCRX shareholders, filed in April 2018. http://securities.stanford.edu/filings-documents/1064/OTI00_06/2018426_r01c_17CV06687.pdf The case was dismissed but I believe it is pending an appeal by plantiff http://securities.stanford.edu/filings-documents/1064/OTI00_06/20181210_r01x_17CV06687.pdf Meanwhile, we hear nothing about the milestone payments and the CVR's just sit there.